A person's level of immunologic resilience -- regardless of age -- can predict his or her COVID-19 outcome, a new study has found. Researchers from The University of Texas Health Science Center at San ...

A close-up of a biopharmaceutical research laboratory, with a microscope in the foreground. MoonLake Immunotherapeutics (NASDAQ:MLTX) is a Switzerland-based clinical-stage biopharmaceutical company ...

The bacterium that causes tuberculosis has a cousin you've never heard of: MAC. This bacterial complex is everywhere, but most people never show symptoms. Yet some people get very, very sick.

To clarify the association between certain immunologic factors and clinical activity in patients with systemic lupus erythematosus, 96 patients were studied. Those with antibodies to deoxyribonucleic ...

Preoperative Mitomycin, Ifosfamide, and Cisplatin Followed by Esophagectomy in Squamous Cell Carcinoma of the Esophagus: Pathologic Complete Response Induced by Chemotherapy Leads to Long-Term ...

This week, Bobbi Conner talks with Dr. Katherine Chetta about the science of breast milk. Dr. Chetta is an Assistant Professor of Pediatrics and a neonatologist at MUSC Shawn Jenkins Children’s ...

MoonLake Immunotherapeutics (NASDAQ:MLTX) is one of the 10 Stocks with Huge Catalysts on the Horizon. The company speeds up the clinical momentum with phase 3 trials, expanded indications, and ...